Companies / Alevin Therapeutics
Alevin Therapeutics
Cambridge, United Kingdom
Alevin Therapeutics develops transformative safe and effective medicines for patients with life-threatening fibrotic diseases through targeted integrin therapies
Alevin Therapeutics, based in Cambridge, United Kingdom, has 2 investors on file, among them Nottingham Technology Ventures and o2h Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor | |
| Portfolio page | Venture capital |
More from Nottingham Technology Ventures
36 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (47%), Industrial & Manufacturing (20%), AI & Machine Learning (12%).
See Nottingham Technology Ventures' full profile · Who invests alongside it
More from o2h Ventures
36 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (94%), Enterprise Software (3%), AI & Machine Learning (3%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Alevin Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Nottingham Technology Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/alevintherapeutics.com/investors
# also
GET /v1/companies/alevintherapeutics.com
GET /v1/companies/alevintherapeutics.com/news